Role of Activating Transcription Factor 3 (ATF3) in Endoplasmic Reticulum (ER) stress-induced sensitization of p53-deficient human colon cancer cells to Tumor Necrosis Factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through up-regulation of Death Receptor 5 (DR5) by zerumbone and celecoxib

Journal of Biological Chemistry

Volumn 289, Issue 31, 2014, Pages 21544-21561

  Edagawa, Makoto ^a,b   Kawauchi, Junya ^a   Hirata, Manabu ^a   Goshima, Hiroto ^a   Inoue, Makoto ^a   Okamoto, Tatsuro ^b   Murakami, Akira ^c   Maehara, Yoshihiko ^b   Kitajima, Shigetaka ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; CHEMICAL ACTIVATION; DISEASES; LIGANDS; PROTEINS; TRANSCRIPTION FACTORS;

ACTIVATING TRANSCRIPTION FACTOR; COLORECTAL CANCER CELL; ENDOPLASMIC RETICULUM STRESS; ENHANCER BINDING PROTEINS; HUMAN COLON CANCER CELLS; STRESS RESPONSE GENES; TRANSMEMBRANE RECEPTORS; TUMOR NECROSIS FACTORS;

TRANSCRIPTION;

ACTIVATING TRANSCRIPTION FACTOR 3; ACTIVATING TRANSCRIPTION FACTOR 4; CCAAT ENHANCER BINDING PROTEIN; CELECOXIB; CYCLIC AMP; DEATH RECEPTOR 5; MESSENGER RNA; PROTEIN KINASE R; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; ZERUMBONE; ATF3 PROTEIN, HUMAN; PRIMER DNA; PYRAZOLE DERIVATIVE; SESQUITERPENE; SULFONAMIDE; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL LINE; COLON CANCER; DRUG SENSITIZATION; EMBRYO; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN MOTIF; RECEPTOR UPREGULATION; SEQUENCE HOMOLOGY; COLON TUMOR; DRUG EFFECTS; ENDOPLASMIC RETICULUM; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ACTIVATING TRANSCRIPTION FACTOR 3; APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; COLONIC NEOPLASMS; DNA PRIMERS; ENDOPLASMIC RETICULUM; HUMANS; PROMOTER REGIONS, GENETIC; PYRAZOLES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SESQUITERPENES; SULFONAMIDES; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84905392984     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.558890     Document Type: Article

References (62)

1. Hanahan, D., and Weinberg, R. A. (2011) The hallmarks of cancer: the next generation. Cell 144, 646-674
2. Farczádi, E., Szántó, J., Kaszás, I., Benyó, I., Bodnár, Z., Szlobodnyik, J., and Szende, B. (1999) Changes in apoptotic and mitotic activity in rectal carcinoma after short-term cytostatic therapy as possible predictive factors. Neoplasma 46, 219-223
3. Scott, N., Hale, A., Deakin, M., Hand, P., Adab, F. A., Hall, C., Williams, G. T., and Elder, J. B. (1998) A histopathological assessment of the response of rectal adenocarcinoma to combination chemo-radiotherapy: relationship to apoptotic activity, p53 and bcl-2 expression. Eur. J. Surg. Oncol. 24, 169-173 (Pubitemid 28260606)
4. Pan, G., Ni, J., Wei, Y. F., Yu, G., Gentz, R., and Dixit, V. M. (1997) An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277, 815-818 (Pubitemid 27366732)
5. Walczak, H., Degli-Esposti, M. A., Johnson, R. S., Smolak, P. J., Waugh, J. Y., Boiani, N., Timour, M. S., Gerhart, M. J., Schooley, K. A., Smith, C. A., Goodwin, R. G., and Rauch, C. T. (1997) TRAIL-R2: a novel apoptosismediating receptor for TRAIL. EMBO J. 16, 5386-5397 (Pubitemid 27380146)
6. Wu, G. S., Burns, T. F., McDonald, E. R., 3rd, Jiang, W., Meng, R., Krantz, I. D., Kao, G., Gan, D. D., Zhou, J. Y., Muschel, R., Hamilton, S. R., Spinner, N. B., Markowitz, S., Wu, G., and el-Deiry, W. S. (1997) KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet. 17, 141-143
7. Chaudhary, P. M., Eby, M., Jasmin, A., Bookwalter, A., Murray, J., and Hood, L. (1997) Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway. Immunity 7, 821-830 (Pubitemid 28064895)
8. Gonzalvez, F., and Ashkenazi, A. (2010) New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene 29, 4752-4765
9. Dimberg, L. Y., Anderson, C. K., Camidge, R., Behbakht, K., Thorburn, A., and Ford, H. L. (2013) On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics. Oncogene 32, 1341-1350
10. Sheikh, M. S., Burns, T. F., Huang, Y., Wu, G. S., Amundson, S., Brooks, K. S., Fornace, A. J. Jr., and el-Deiry, W. S. (1998) p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor α. Cancer Res. 58, 1593-1598 (Pubitemid 28215076)
11. Xiang, H., Fox, J. A., Totpal, K., Aikawa, M., Dupree, K., Sinicropi, D., Lowe, J., and Escandón, E. (2002) Enhanced tumor killing by Apo2L/ TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors. Oncogene 21, 3611-3619 (Pubitemid 34587693)
12. Taketani, K., Kawauchi, J., Tanaka-Okamoto, M., Ishizaki, H., Tanaka, Y., Sakai, T., Miyoshi, J., Maehara, Y., and Kitajima, S. (2012) Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells. Oncogene 31, 2210-2221
13. Malhotra, J. D., and Kaufman, R. J. (2007) The endoplasmic reticulum and the unfolded protein response. Semin. Cell Dev. Biol. 18, 716-731 (Pubitemid 350138453)
14. Ron, D., and Walter, P. (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 8, 519-529 (Pubitemid 46985379)
15. Malhotra, J. D., and Kaufman, R. J. (2007) Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid. Redox Signal 9, 2277-2293 (Pubitemid 350059010)
16. Higa, A., and Chevet, E. (2012) Redox signaling loops in the unfolded protein response. Cell. Signal. 24, 1548-1555
17. Ma, Y., and Hendershot, L. M. (2004) The role of the unfolded protein response in tumour development: friend or foe? Nat. Rev. Cancer 4, 966-977 (Pubitemid 39626220)
18. Yamaguchi, H., and Wang, H. G. (2004) CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. J. Biol. Chem. 279, 45495-45502 (Pubitemid 39491535)
19. Moon, D. O., Park, S. Y., Choi, Y. H., Ahn, J. S., and Kim, G. Y. (2011) Guggulsterone sensitizes hepatoma cells to TRAIL-induced apoptosis through the induction of CHOP-dependent DR5: involvement of ROSdependent ER-stress. Biochem. Pharmacol. 82, 1641-1650
20. Xu, L., Su, L., and Liu, X. (2012) PKCδ regulates death receptor 5 expression induced by PS-341 through ATF4-ATF3/CHOP axis in human lung cancer cells. Mol. Cancer Ther. 11, 2174-2182
21. Kim, Y. H., Park, J. W., Lee, J. Y., and Kwon, T. K. (2004) Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells. Carcinogenesis 25, 1813-1820
22. Hai, T., Wolfgang, C. D., Marsee, D. K., Allen, A. E., and Sivaprasad, U. (1999) ATF3 and stress responses. Gene Expr. 7, 321-335 (Pubitemid 29372076)
23. Zhang, C., Gao, C., Kawauchi, J., Hashimoto, Y., Tsuchida, N., and Kitajima, S. (2002) Transcriptional activation of the human stress-inducible transcriptional repressor ATF3 gene promoter by p53. Biochem. Biophys. Res. Commun. 297, 1302-1310 (Pubitemid 35216389)
24. Wei, C. L., Wu, Q., Vega, V. B., Chiu, K. P., Ng, P., Zhang, T., Shahab, A., Yong, H. C., Fu, Y., Weng, Z., Liu, J., Zhao, X. D., Chew, J. L., Lee, Y. L., Kuznetsov, V. A., Sung, W. K., Miller, L. D., Lim, B., Liu, E. T., Yu, Q., Ng, H. H., and Ruan, Y. (2006) A global map of p53 transcription-factor binding sites in the human genome. Cell 124, 207-219 (Pubitemid 43069320)
25. Riley, T., Sontag, E., Chen, P., and Levine, A. (2008) Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol. 9, 402-412 (Pubitemid 351574202)
26. Jiang, H. Y., Wek, S. A., McGrath, B. C., Lu, D., Hai, T., Harding, H. P., Wang, X., Ron, D., Cavener, D. R., and Wek, R. C. (2004) Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response. Mol. Cell Biol. 24, 1365-1377 (Pubitemid 38112196)
27. Cai, Y., Zhang, C., Nawa, T., Aso, T., Tanaka, M., Oshiro, S., Ichijo, H., and Kitajima, S. (2000) Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells: activation of c-Jun NH(2)-terminal kinase and promoter response element. Blood 96, 2140-2148
28. Gjymishka, A., Su, N., and Kilberg, M. S. (2009) Transcriptional induction of the human asparagine synthetase gene during the unfolded protein response does not require the ATF6 and IRE1/XBP1 arms of the pathway. Biochem. J. 417, 695-703
29. Kim, M., Miyamoto, S., Yasui, Y., Oyama, T., Murakami, A., and Tanaka, T. (2009) Zerumbone, a tropical ginger sesquiterpene, inhibits colon and lung carcinogenesis in mice. Int. J. Cancer 124, 264-271
30. Yodkeeree, S., Sung, B., Limtrakul, P., and Aggarwal, B. B. (2009) Zerumbone enhances TRAIL-induced apoptosis through the induction of death receptors in human colon cancer cells: Evidence for an essential role of reactive oxygen species. Cancer Res. 69, 6581-6589
31. Prasannan, R., Kalesh, K. A., Shanmugam, M. K., Nachiyappan, A., Ramachandran, L., Nguyen, A. H., Kumar, A. P., Lakshmanan, M., Ahn, K. S., and Sethi, G. (2012) Key cell signaling pathways modulated by zerumbone: role in the prevention and treatment of cancer. Biochem. Pharmacol. 84, 1268-1276
32. Liu, X., Yue, P., Zhou, Z., Khuri, F. R., and Sun, S. Y. (2004) Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J. Natl. Cancer Inst. 96, 1769-1780 (Pubitemid 39654571)
33. He, Q., Luo, X., Jin, W., Huang, Y., Reddy, M. V., Reddy, E. P., and Sheikh, M. S. (2008) Celecoxib and a novel COX-2 inhibitor ON09310 up-regulate death receptor 5 expression via GADD153/CHOP. Oncogene 27, 2656-2660 (Pubitemid 351550874)
34. Oh, Y. T., Liu, X., Yue, P., Kang, S., Chen, J., Taunton, J., Khuri, F. R., and Sun, S. Y. (2010) ERK/ribosomal S6 kinase (RSK) signaling positively regulates death receptor 5 expression through co-activation of CHOP and Elk1. J. Biol. Chem. 285, 41310-41319
35. Grösch, S., Tegeder, I., Niederberger, E., Bräutigam, L., and Geisslinger, G. (2001) COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. FASEB J. 15, 2742-2744
36. Ohnishi, K., Ohkura, S., Nakahata, E., Ishisaka, A., Kawai, Y., Terao, J., Mori, T., Ishii, T., Nakayama, T., Kioka, N., Matsumoto, S., Ikeda, Y., Akiyama, M., Irie, K., and Murakami, A. (2013) Non-specific protein modifications by a phytochemical induce heat shock response for self-defense. PloS ONE 8, e58641
37. Ohnishi, K., Nakahata, E., Irie, K., and Murakami, A. (2013) Zerumbone, an electrophilic sesquiterpene, induces cellular proteo-stress leading to activation of ubiquitin-proteasome system and autophagy. Biochem. Biophys. Res. Commun. 430, 616-622
38. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221
39. Kawauchi, J., Zhang, C., Nobori, K., Hashimoto, Y., Adachi, M. T., Noda, A., Sunamori, M., and Kitajima, S. (2002) Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis factor-α-induced apoptosis through down-regulation of p53 transcription. J. Biol. Chem. 277, 39025-39034 (Pubitemid 35154769)
40. Morita, S., Kojima, T., and Kitamura, T. (2000) Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7, 1063-1066 (Pubitemid 30398356)
41. Wagner, K. W., Punnoose, E. A., Januario, T., Lawrence, D. A., Pitti, R. M., Lancaster, K., Lee, D., von Goetz, M., Yee, S. F., Totpal, K., Huw, L., Katta, V., Cavet, G., Hymowitz, S. G., Amler, L., and Ashkenazi, A. (2007) Deathreceptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat. Med. 13, 1070-1077 (Pubitemid 47517508)
42. Zhang, C., Kawauchi, J., Adachi, M. T., Hashimoto, Y., Oshiro, S., Aso, T., and Kitajima, S. (2001) Activation of JNK and transcriptional repressor ATF3/LRF1 through the IRE1/TRAF2 pathway is implicated in human vascular endothelial cell death by homocysteine. Biochem. Biophys. Res. Commun. 289, 718-724 (Pubitemid 33152292)
43. Chen, B. P., Wolfgang, C. D., and Hai, T. (1996) Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10. Mol. Cell Biol. 16, 1157-1168 (Pubitemid 26061687)
44. Wolfgang, C. D., Chen, B. P., Martindale, J. L., Holbrook, N. J., and Hai, T. (1997) Gadd153/Chop10, a potential target gene of the transcriptional repressor ATF3. Mol. Cell Biol. 17, 6700-6707 (Pubitemid 27451217)
45. Ravasi, T., Suzuki, H., Cannistraci, C. V., Katayama, S., Bajic, V. B., Tan, K., Akalin, A., Schmeier, S., Kanamori-Katayama, M., Bertin, N., Carninci, P., Daub, C. O., Forrest, A. R., Gough, J., Grimmond, S., Han, J. H., Hashimoto, T., Hide, W., Hofmann, O., Kamburov, A., Kaur, M., Kawaji, H., Kubosaki, A., Lassmann, T., van Nimwegen, E., MacPherson, C. R., Ogawa, C., Radovanovic, A., Schwartz, A., Teasdale, R. D., Tegnér, J., Lenhard, B., Teichmann, S. A., Arakawa, T., Ninomiya, N., Murakami, K., Tagami, M., Fukuda, S., Imamura, K., Kai, C., Ishihara, R., Kitazume, Y., Kawai, J., Hume, D. A., Ideker, T., and Hayashizaki, Y. (2010) An atlas of combinatorial transcriptional regulation in mouse and man. Cell 140, 744-752
46. Ravi, R., Bedi, G. C., Engstrom, L. W., Zeng, Q., Mookerjee, B., Gélinas, C., Fuchs, E. J., and Bedi, A. (2001) Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-κB. Nat. Cell Biol. 3, 409-416 (Pubitemid 32288449)
47. Shetty, S., Graham, B. A., Brown, J. G., Hu, X., Vegh-Yarema, N., Harding, G., Paul, J. T., and Gibson, S. B. (2005) Transcription factor NF-κB differentially regulates death receptor 5 expression involving histone deacetylase 1. Mol. Cell Biol. 25, 5404-5416 (Pubitemid 40853578)
48. Takada, Y., Murakami, A., and Aggarwal, B. B. (2005) Zerumbone abolishes NF-κB and IκBα kinase activation leading to suppression of antiapoptotic and metastatic gene expression, up-regulation of apoptosis, and downregulation of invasion. Oncogene 24, 6957-6969 (Pubitemid 41509418)
49. Gyrd-Hansen, M., and Meier, P. (2010) IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer. Nat. Rev. Cancer 10, 561-574
50. Kaszubska, W., Hooft van Huijsduijnen, R., Ghersa, P., DeRaemy-Schenk, A. M., Chen, B. P., Hai, T., DeLamarter, J. F., and Whelan, J. (1993) Cyclic AMP-independent ATF family members interact with NF-κB and function in the activation of the E-selectin promoter in response to cytokines. Mol. Cell Biol. 13, 7180-7190 (Pubitemid 23321170)
51. Hua, B., Tamamori-Adachi, M., Luo, Y., Tamura, K., Morioka, M., Fukuda, M., Tanaka, Y., and Kitajima, S. (2006) A splice variant of stress response gene ATF3 counteracts NF-κB-dependent anti-apoptosis through inhibiting recruitment of CREB-binding protein/p300 coactivator. J. Biol. Chem. 281, 1620-1629
52. Gilchrist, M., Thorsson, V., Li, B., Rust, A. G., Korb, M., Roach, J. C., Kennedy, K., Hai, T., Bolouri, H., and Aderem, A. (2006) Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441, 173-178
53. Shin, J. W., Ohnishi, K., Murakami, A., Lee, J. S., Kundu, J. K., Na, H. K., Ohigashi, H., and Surh, Y. J. (2011) Zerumbone induces heme oxygenase-1 expression in mouse skin and cultured murine epidermal cells through activation of Nrf2. Cancer Prev. Res. (Phila.) 4, 860-870
54. Sobhan, P. K., Seervi, M., Deb, L., Varghese, S., Soman, A., Joseph, J., Mathew, K. A., Raghu, G., Thomas, G., E. S., S. M., and R. S. K. (2013) Calpain and reactive oxygen species targets Bax for mitochondrial permeabilisation and caspase activation in zerumbone induced apoptosis. PloS ONE 8, e59350
55. Grösch, S., Maier, T. J., Schiffmann, S., and Geisslinger, G. (2006) Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J. Natl. Cancer Inst. 98, 736-747
56. Tsutsumi, S., Namba, T., Tanaka, K. I., Arai, Y., Ishihara, T., Aburaya, M., Mima, S., Hoshino, T., and Mizushima, T. (2006) Celecoxib upregulates endoplasmic reticulum chaperones that inhibit celecoxib-induced apoptosis in human gastric cells. Oncogene 25, 1018-1029 (Pubitemid 43277010)
57. Kardosh, A., Golden, E. B., Pyrko, P., Uddin, J., Hofman, F. M., Chen, T. C., Louie, S. G., Petasis, N. A., and Schönthal, A. H. (2008) Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib. Cancer Res. 68, 843-851 (Pubitemid 351206762)
58. Hamdulay, S. S., Wang, B., Birdsey, G. M., Ali, F., Dumont, O., Evans, P. C., Haskard, D. O., Wheeler-Jones, C. P., and Mason, J. C. (2010) Celecoxib activates PI-3K/Akt and mitochondrial redox signaling to enhance heme oxygenase-1-mediated anti-inflammatory activity in vascular endothelium. Free Radic. Biol. Med. 48, 1013-1023
59. Ohnishi, K., Irie, K., and Murakami, A. (2009) In vitro covalent binding proteins of zerumbone, a chemopreventive food factor. Biosci. Biotechnol. Biochem. 73, 1905-1907
60. Gao, M., Yeh, P. Y., Lu, Y. S., Hsu, C. H., Chen, K. F., Lee, W. C., Feng, W. C., Chen, C. S., Kuo, M. L., and Cheng, A. L. (2008) OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma. Cancer Res. 68, 9348-9357
61. Jin, Z., McDonald, E. R., 3rd, Dicker, D. T., and El-Deiry, W. S. (2004) Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis. J. Biol. Chem. 279, 35829-35839 (Pubitemid 39100590)
62. Kojima, Y., Nakayama, M., Nishina, T., Nakano, H., Koyanagi, M., Takeda, K., Okumura, K., and Yagita, H. (2011) Importin β1 protein-mediatednuclear localization of death receptor 5 (DR5) limits DR5/ tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced cell death of human tumor cells. J. Biol. Chem. 286, 43383-43393